FDA-Drug2026-10-26Class IIPROCESSING DEFECT
Strides Pharma Cinacalcet 30 mg tablets recalled for failed dissolution specifications
What this means
Strides Pharma is recalling one lot of Cinacalcet 30 mg tablets because they failed to meet dissolution specifications, meaning the tablets may not break down properly in the body. This could result in inconsistent or reduced drug effectiveness. The affected lot is 7717825A, expiring 11/30/2028.
- Check if your Cinacalcet prescription matches lot 7717825A
- Contact your pharmacist or doctor if you have this lot before taking more doses
- Do not stop taking your medication without speaking to your doctor first
The agency's original wording
Hazard
Failed dissolution specifications
Intended for
Adults
Illnesses reported
None reported
Sold states
US Nationwide
Affected count
49,488 30-count bottles
Manufactured in
200 Crossing Blvd Ste 110, Bridgewater, New Jersey, United States
Products
Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, 605 014, India; Distributed by: Strides Pharma Inc. Bridgewater, NJ 08807, NDC 64380-883-04
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0079-2027Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.